Chemical Compound
cefbuperazone sodium
CAS Registry Number
76648-01-6
Primary Record
cefbuperazone sodium
Note: Only for scientific research or as raw materials for production.
- In stock
- 8,153 g
- Purity
- 99.7 %
- CAS
- 76648-01-6
Compound Identifiers & Properties
- CAS
- 76648-01-6
- PubChem CID
- 23663968
- SMILES
- CCN1CCN(C(=O)C1=O)C(=O)N[C@H]([C@H](C)O)C(=O)N[C@]2([C@@H]3N(C2=O)C(=C(CS3)CSC4=NN=NN4C)C(=O)[O-])OC.[Na+]
- Canonical SMILES
- CCN1CCN(C(=O)N[C@@H](C(=O)N[C@]2(OC)C(=O)N3C(C(=O)[O-])=C(CSc4nnnn4C)CS[C@@H]32)[C@H](C)O)C(=O)C1=O.[Na+]
Names & Synonyms
- cefbuperazone sodium
- Cefbuperazona
- Cefbuperazonum
- Cefbuperzaone
- Keiperazon
- Tomiporan
- Cefbuperazonesodium
- Keiperazon (TN)
- CEFBUPERAZONE
- Cefbuperazone sodium salt
- Cefbuperazone (sodium)
- Cefbuperazone sodium [JAN]
- 76648-01-6
- 1VX59V96BS
- UNII-1VX59V96BS
- RefChem:1081313
- AC1Q1VQ9
- AC1Q1W0Y
- Cefbuperazone sodium (JP18)
- C22H27N9O9S.Na
- DTXSID50227467
- SCHEMBL27793363
- 76648-01-6(sodium)
- CHEBI:31365
- DTXCID50149958
- C22-H27-N9-O9-S.Na
- AR-1L5329
- BMY-25182
- CEFBUPERAZONE SODIUM [MART.]
- CID127526
- CEFBUPERAZONE SODIUM [WHO-DD]
- AKOS005146216
- CEFBUPERAZONE SODIUM SALT [MI]
- AC-5601
- T-1982
- AN-10796
- T 1982
- LS-150051
- CS-0079896
- D01736
- A899955
- I14-11166
- Q27252962
- sodium;(6R,7S)-7-[[(2R,3S)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-3-hydroxybutanoyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(2-((2,3-dioxo-4-ethyl-1-piperazinyl)formamido)-3-hydroxybutyramido)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-, monosodium salt, (6R-(6-alpha,7-alpha,7(2R*,3S*)))-
- sodium (6R,7S)-7-[[(2R,3S)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-3-hydroxybutanoyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- sodium(6r,7s)-7-({n-[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]-d-threonyl}amino)-7-methoxy-3-{[(1-methyl-1h-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- 5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLIC ACID, 7-(((2R,3S)-2-(((4-ETHYL-2,3-DIOXO-1-PIPERAZINYL)CARBONYL)AMINO)-3-HYDROXY-1-OXOBUTYL)AMINO)-7-METHOXY-3-(((1-METHYL-1H-TETRAZOL-5-YL)THIO)METHYL)-8-OXO-, SODIUM SALT (1:1), (6R,7S)-
- 5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLIC ACID, 7-(2-((2,3-DIOXO-4-ETHYL-1-PIPERAZINYL)FORMAMIDO)-3-HYDROXYBUTYRAMIDO)-7-METHOXY- 3-(((1-METHYL-1H-TETRAZOL-5-YL)THIO)METHYL)-8-OXO-, MONOSODIUM SALT, (6R-(6-ALPHA,7-ALPHA,7(2R*,3S*)))-
- 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2R,3S)-2-[[(4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl]amino]-3-hydroxy-1-oxobutyl]amino]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-, monosodium salt, (6R,7S)-
- 76610-84-9
- 80797-03-1
- Monosodium (6R,7S)-7-((2R,3S)-2-((4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino)-3-hydroxybutanoylamino)-7-methoxy-3-(1-methyl-1H-tetrazol-5-ylsulfanylmethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate
- sodium (6R,7S)-7-[[(2R,3S)-2-[(4-ethyl-2,3-dioxo-piperazine-1-carbonyl)amino]-3-hydroxy-butanoyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- Sodium (6R,7S)-7-[N-(4-ethyl-2,3-dioxopiperazine-1-carbonyl)-D-threonamido]-7-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- sodium,(6R,7S)-7-[[(2R,3S)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-3-hydroxybutanoyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate